Rare diseases
Investigational molecules
Locations
382 conditions with trials, the busiest first
1 304 trials across Europe, recruiting first
Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
AustriaSafety and Tolerability of Benralizumab in Patients with HES, EGPA, or Asthma Who Completed a Prior Study
AustriaStudy of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
CzechiaA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
FrancePhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
AustriaStudy of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
BulgariaA study to evaluate the effects of zenagamtide in people with overweight or obesity and obstructive sleep apnoea not treated with positive airway pressure
DenmarkA study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer
FranceStudy of zenagamtide for weight loss and sleep improvement in patients with obesity and obstructive sleep apnea using positive airway pressure therapy
GermanyStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
BelgiumPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
AustriaA Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma
FranceThe therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
